Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entheon Biomedical Corp C.ENBI

Alternate Symbol(s):  ENTBF

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.


CSE:ENBI - Post by User

Entheon Biomedical Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Post by Viralstocks1on Jun 16, 2021 3:23pm
189 Views
Post# 33396471

Agreement to Acquire Lobo Genetics Inc.

Agreement to Acquire Lobo Genetics Inc.News Release (16-06-21): Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.. Read here: https://www.marketscreener.com/quote/stock/ENTHEON-BIOMEDICAL-CORP-43256782/news/Entheon-Biomedical-Corp-Announces-Agreement-to-Acquire-Lobo-Genetics-Inc-35622889/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities